NEW YORK (GenomeWeb News) – BioDiscovery said last week that the National Cancer Institute has obtained a site license for its Nexus Copy Number software, which is used to analyze and visualize chromosomal aberrations from microarray data.
 
Nexus Copy Number can integrate data from thousands of arrays along with their clinical annotations in a single project, the company said.
 
Financial terms of the licensing agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.